MedTrace Logo

Registry Maastro Applicator

NCT07501845 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 999

Last updated 2026-04-13

No results posted yet for this study

Summary

This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.

Conditions

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Maaike Berbée, MD, PhD · Maastro

  • Britt Hupkens, MD, PhD · Maastro

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-23
Primary Completion
2034-04-01
Completion
2034-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501845 on ClinicalTrials.gov